| Purity: | 99% |
|---|---|
| Model Number: | CAS NO.: 98319-26-7 |
| Brand Name: | NJ |
| Grade Standard: | |
| Type: | |
| Place of Origin: | China (Mainland) |
| EINECS No.: | * |
| MF: | C23H36N2O2 |
| Other Names: | MK-906 |
| CAS No.: | 98319-26-7 |
Quick Details
Specifications
Effective 99% Purity Pharmaceutical Grade Steroids Powders CAS 98319-26-7 Finasteride For Hair Loss
Quick Detail :
Product Name: Finasteride
Synonyms: PROSCAR;PROSTIDE;N-(2-METHYL-2-PROPYL)-3-OXO-4-AZA-5ALPHA-ANDROST-1-ENE-17BETA-CARBOXAMIDE;MK-906;(5alpha,17beta)-(1,1-dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide;17beta-(n-tert-butylcarbamoyl)-4-aza-5alpha-androst-1-en-3-one;4-azaandrost-1-ene-17-carboxamide,n-(1,1-dimethylethyl)-3-oxo-,(5-alpha,17-be;4-azaandrost-1-ene-17-carboxamide,n-(1,1-dimethylethyl)-3-oxo-,(5alpha,17beta
CAS: 98319-26-7
MF: C23H36N2O2
MW: 372.54
Product Categories: Active Pharmaceutical Ingredients;API;Biochemistry;Steroids;Steroids (Others);Intermediates & Fine Chemicals;Pharmaceuticals;Vitamin Ingredients;Intracellular receptor;Steroid and Hormone;PROSCAR;Hormone Drugs
MP 253 °C
Storage temp. Store at RT
Chemical Properties: Off-White Crystalline Powder
Usage: Inhibitor of 5α-reductase, the enzyme which converts testosterone to the more potent androgen, 5α-dihydrotestosterone. Antialopecia agent.
Usage : anti-androgen, alpha-reductase inhibitor
Usage : Treatment of benign prostatic hyperplasia and androgenetic alopecia
Usage : Inhibitor of 5a-reductase, the enzyme which converts testosterone to the more potent androgen, 5a-dihydrotestosterone. Antialopecia agent .
Usage : Use for the treatment of male diseases such as prostate hypertrophy and alopecia.
Description :
Finasteride is China a benign prostatic hyperplasia and prostatitis based drug treatment, it is 4 - nitrogen steroid hormone compounds of the synthesis, belonging to resistance hormone drugs, can be selective inhibition of 5α- reductase, enable the conversion of testosterone into resistance 5α dihydrotestosterone (DHT), front row in glandular cells of the male hormone levels drop, reduce the serum prostate specific antigen, reduce the prostate volume increased, urine flow increased, thereby reducing symptoms to achieve the purpose for the treatment of benign prostatic hyperplasia.
Prostatic hyperplasia is called hypertrophy of the prostate, leading to the bladder neck and urethra oppressed, causing urinary tract obstruction and other symptoms and complications, so that patients feel pain, multiple men over the age of 50 .
Quick Detail :
Product Name: Finasteride
Synonyms: PROSCAR;PROSTIDE;N-(2-METHYL-2-PROPYL)-3-OXO-4-AZA-5ALPHA-ANDROST-1-ENE-17BETA-CARBOXAMIDE;MK-906;(5alpha,17beta)-(1,1-dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide;17beta-(n-tert-butylcarbamoyl)-4-aza-5alpha-androst-1-en-3-one;4-azaandrost-1-ene-17-carboxamide,n-(1,1-dimethylethyl)-3-oxo-,(5-alpha,17-be;4-azaandrost-1-ene-17-carboxamide,n-(1,1-dimethylethyl)-3-oxo-,(5alpha,17beta
CAS: 98319-26-7
MF: C23H36N2O2
MW: 372.54
Product Categories: Active Pharmaceutical Ingredients;API;Biochemistry;Steroids;Steroids (Others);Intermediates & Fine Chemicals;Pharmaceuticals;Vitamin Ingredients;Intracellular receptor;Steroid and Hormone;PROSCAR;Hormone Drugs
MP 253 °C
Storage temp. Store at RT
Chemical Properties: Off-White Crystalline Powder
Usage: Inhibitor of 5α-reductase, the enzyme which converts testosterone to the more potent androgen, 5α-dihydrotestosterone. Antialopecia agent.
Usage : anti-androgen, alpha-reductase inhibitor
Usage : Treatment of benign prostatic hyperplasia and androgenetic alopecia
Usage : Inhibitor of 5a-reductase, the enzyme which converts testosterone to the more potent androgen, 5a-dihydrotestosterone. Antialopecia agent .
Usage : Use for the treatment of male diseases such as prostate hypertrophy and alopecia.
Description :
Finasteride is China a benign prostatic hyperplasia and prostatitis based drug treatment, it is 4 - nitrogen steroid hormone compounds of the synthesis, belonging to resistance hormone drugs, can be selective inhibition of 5α- reductase, enable the conversion of testosterone into resistance 5α dihydrotestosterone (DHT), front row in glandular cells of the male hormone levels drop, reduce the serum prostate specific antigen, reduce the prostate volume increased, urine flow increased, thereby reducing symptoms to achieve the purpose for the treatment of benign prostatic hyperplasia.
Prostatic hyperplasia is called hypertrophy of the prostate, leading to the bladder neck and urethra oppressed, causing urinary tract obstruction and other symptoms and complications, so that patients feel pain, multiple men over the age of 50 .
Pharmaceutical Intermediates:
Dexamethasone CAS:50-02-2
Dutasteride CAS:164656-23-9
Finasteride CAS:98319-26-7
Formestane CAS:566-48-3
Cabergoline CAS:81409-90-7
Paclitaxel CAS:33069-62-4
Phenacetin CAS:62-44-2
Paracetamol CAS:103-90-2
GBL/Gamma-Butyrolactone CAS:96-48-0
BA/Benzyl alcohol CAS:100-51-6
BB/Benzyl benzoate CAS:120-51-4
Grape seed oil CAS:85594-37-2
ETHYL OLEATE CAS:111-62-6